A Phase 4 interventional study of Vitamin D in Asthma, sponsored by Augusta University. Completed at 1 site in United States. Open to participants aged 7 Years to 17 Years. Per ClinicalTrials.gov, last updated 2012-10-23.
Sponsored by Augusta University · Phase 4, Interventional, and Treatment
The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 10 is below the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →Augusta University is the lead sponsor of 177 studies on the registry; 24 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Vitamin D
Drug: Vitamin D
Vitamin D 2000 IU daily pill Vitamin D 400 IU daily pill
Change in Pulmonary Function Test (PFT) after vitamin D supplementation
Time frame: 4 weeks
Change in Asthma Control Test (ACT) scores after vitamin D supplementation
Time frame: 4-week
This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Augusta University